Log In
Print
BCIQ
Print
Print this Print this
 

Pollinex-R Ragweed vaccine

  Manage Alerts
Collapse Summary General Information
Company Allergy Therapeutics plc
DescriptionSubcutaneous ragweed allergy vaccine formulated with allergoids and tyrosine
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationAllergy
Indication DetailsTreat ragweed allergy
Regulatory Designation

Partner

Endo International plc; Takeda Pharmaceutical Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today